| 000 | 01762 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518074500.0 | ||
| 264 | 0 | _c20201020 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-019-2073-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScarneo, Scott A | |
| 245 | 0 | 0 |
_aPharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c12 2019 |
||
| 300 |
_a292 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArthritis, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xmetabolism |
| 650 | 0 | 4 |
_aBenzamides _xpharmacokinetics |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacokinetics |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aKnee Joint _xdrug effects |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSynoviocytes _xdrug effects |
| 700 | 1 | _aEibschutz, Liesl S | |
| 700 | 1 | _aBendele, Phillip J | |
| 700 | 1 | _aYang, Kelly W | |
| 700 | 1 | _aTotzke, Juliane | |
| 700 | 1 | _aHughes, Philip | |
| 700 | 1 | _aFox, David A | |
| 700 | 1 | _aHaystead, Timothy A J | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 21 _gno. 1 _gp. 292 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-019-2073-x _zAvailable from publisher's website |
| 999 |
_c30431143 _d30431143 |
||